MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Clinical trials for MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) explained in plain language.
Never miss a new study
Get alerted when new MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) trials appear
Sign up with your email to follow new studies for MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare mitochondrial disease: oral drug trial launches
Disease control Recruiting nowThis study tests an oral medication called TTI-0102 in 12 people with MELAS, a rare genetic disorder that causes muscle weakness, strokes, and fatigue. Participants receive either the drug or a placebo for 6 months to see if it improves walking distance, tiredness, and quality of…
Matched conditions: MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
Hope for mitochondrial patients: new drug targets debilitating fatigue
Symptom relief Recruiting nowThis study tests whether the experimental drug sonlicromanol can reduce fatigue and improve physical abilities like balance and leg strength in adults with a specific genetic mitochondrial disease (m.3243A>G mutation). About 220 participants will receive either the drug or a plac…
Matched conditions: MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC